Led · Equity · Sep 2025

Wooclap is an EdTech platform that converts passive lectures and training sessions into interactive experiences using dozens of activities (polls, multiple-choice, word clouds, image annotation) and seamless integrations with LMS and conferencing tools. Founded in 2015 in Brussels by Sébastien Lebbe and Jonathan Alzetta, the platform is used by over 50 million learners globally and is adopted by universities (Sorbonne, University of Sheffield, Duke) and large organisations (Dior, Pernod Ricard, Onepoint, Red Cross). Wooclap emphasizes pedagogical depth and co-construction with education experts, drawing on cognitive science to measure understanding in real time and strengthen skills acquisition. The company also offers Wooflash, an AI-powered microlearning app using spaced repetition to improve retention. Wooclap targets higher education and corporate learning markets and highlights ease of use and integration as core strengths. Future plans include accelerating international growth and further developing AI-powered features to enhance learner engagement. Wooclap is a web-based collaborative platform that turns learners' smartphones into interactive tools for training sessions, conferences, and classes. It enables teachers, trainers, and speakers to create and launch multiple question types (multiple choice, polls, numerical, matching, word clouds) and collect real-time answers and analytics. The solution is designed to be simple and intuitive for both instructors and participants and aims to boost participation, improve learning, and measure audience understanding in real time. Wooclap is used in more than 100 countries by large companies, universities/colleges, and ministries. The company announced a €1.4 million fundraising to better captivate students. Investors named in the raise include Alain Dehaze (CEO of The Adecco Group), Pierre-Olivier Beckers (former CEO of Delhaize) and the SCALE 1 Fund (Be Angels).

Participated · Equity · Feb 2025

neurocare is a Munich-based provider of a mental health platform that empowers clinicians to deliver personalized treatment across psychological and neurological conditions. Its platform embeds tools and methods such as sleep hygiene, rTMS, QEEG and neurofeedback alongside talk therapy and pharmaceuticals. These assets are integrated within a cloud-based solution designed to drive clinician productivity and improve clinical outcomes. Following a detailed assessment of a patient’s condition, the platform supports clinicians in developing individualized, scientifically backed therapy plans for Depression, ADHD, mental performance and other indications. The company intends to use recent funding to further develop its technologies and services and to expand the international footprint of its mental health clinics. neurocare is led by CEO Thomas Mechtersheimer and recently raised EUR 19.3M from external backers. neurocare provides an integrated, personalized treatment approach built around its Digital Therapy Platform (DTP), which supports clinicians in developing individualized therapy plans. The DTP combines psychotherapy, neuromodulation, sleep hygiene and medication to treat a variety of psychological and neurological conditions and to improve self-regulation, resilience and social skills. The platform is used in neurocare’s clinics across the US, the Netherlands and Australia, and is deployed in a growing number of third-party clinics. Led by CEO and founder Thomas Mechtersheimer, the company emphasizes clinically evidenced, cost-effective care for healthcare systems. neurocare plans to use the new funding to accelerate international growth — including US expansion and market entry into the Kingdom of Saudi Arabia — and to support development of new hardware and software innovations. The company recently raised EUR 16M to support these initiatives.